Boston Sci's Watchman Gets Positive Medicare Coverage Policy
This article was originally published in The Gray Sheet
CMS granted national coverage for left atrial appendage closure procedures to prevent stroke under more favorable conditions than what the Medicare agency had proposed in November. This is good news for Boston Scientific, which is ramping up marketing of its Watchman device.
Register for our free email digests: